The clinical symptoms of an HCV infection are variable. Infection with HCV results in a chronic infection in 50 to 80% of cases. The window between HCV acquisition and sero-reactivity is highly variable; up to six months.
The clinical symptoms of an HCV infection are variable. Infection with HCV results in a chronic infection in 50 to 80% of cases. The "window" between HCV acquisition and sero-reactivity is highly variable; up to six months.
The clinical symptoms of an HCV infection are variable. Infection with HCV results in a chronic infection in 50 to 80% of cases. The "window" between HCV acquisition and sero-reactivity is highly variable; up to six months.
Herpes Simplex Virus (HSV) is responsible for several clinically significant human viral diseases, with severity ranging from inapparent to fatal. Clinical manifestations include genital tract infections, neonatal herpes, meningoencephalitis, keratoconjunctivitis, and gingivostomatitis.
Also Known As: HSV type 1
Herpes Simplex Virus (HSV) is responsible for several clinically significant human viral diseases, with severity ranging from inapparent to fatal. Clinical manifestations include genital tract infections, neonatal herpes, meningoencephalitis, keratoconjunctivitis, and gingivostomatitis.
Also Known As: HSV 1&2
Herpes Simplex Virus (HSV) is responsible for several clinically significant human viral diseases, with severity ranging from inapparent to fatal. There are two HSV serotypes that are closely related antigenically. HSV Type 2 is more commonly associated with genital tract and neonatal infections, while HSV Type 1 is more commonly associated with infections of non-genital sites.
Also Known As: HSV 1&2
Herpes Simplex Virus (HSV) is responsible for several clinically significant human viral diseases, with severity ranging from inapparent to fatal. There are two HSV serotypes that are closely related antigenically. HSV Type 2 is more commonly associated with genital tract and neonatal infections.
Also Known As: HSV type 2
This 4th generation HIV Ag/Ab Combo assay is intended to be used as an aid in the diagnosis of HIV1/HIV2 infection, including acute or primary HIV-1 infection.
Also Known As: Rapid, Routine, 4th Gen, P24
This test is used to provide a measurement of HIV genetic material in the blood. This is also known as a “viral load test.” HIV RNA testing is often used to determine how actively the HIV virus is reproducing in a person who has been diagnosed with HIV infection. This test can also be used to monitor the status of infection for a person who is undergoing retroviral therapy.
Human T-lymphocyte virus (HTLV) is a virus that is associated with rare disorders and diseases of the T-lymphocytes. The test measures the presence of antibodies to both strain 1 and 2 in the blood.
Lyme disease is transmitted by a tick vector carrying Borrelia burgdorferi. Immunoblot testing qualitatively examines, with high specificity, antibodies in a patient's specimen.
Also Known As: ELISA, Recent or Past Exposure EIA test
Lyme disease is transmitted by a tick vector carrying Borrelia burgdorferi. Immunoblot testing qualitatively examines, with high specificity, antibodies in a patient's specimen. Immunoblot testing is appropriate for confirming a detected EIA or IFA test result.
Also Known As: Western Blot test
MMR Titer Immunity Test The MMR Titer Immunity test provides quantitative measurements for IgG antibodies to Measles (Rubeola), Mumps, and Rubella. This test is used to determine if a person has protective antibodies to several infectious diseases. Most people in the United States receive MMR vaccinations when they are young. However, the immunity provided by […]
